SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3lw2'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XOQ_B_ROFB501_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)
3lw2 PLASMINOGEN
ACTIVATOR INHIBITOR
1

(Mus
musculus)
3 / 3 MET A  62
ASN A 167
GLN A 322
None
1.02A 1xoqB-3lw2A:
undetectable
1xoqB-3lw2A:
23.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z11_C_8MOC501_0
(CYTOCHROME P450,
FAMILY 2, SUBFAMILY
A, POLYPEPTIDE 6)
3lw2 PLASMINOGEN
ACTIVATOR INHIBITOR
1

(Mus
musculus)
5 / 10 PHE A 278
ILE A 326
ILE A 237
LEU A 275
PHE A 358
None
1.09A 1z11C-3lw2A:
undetectable
1z11C-3lw2A:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z11_D_8MOD501_0
(CYTOCHROME P450,
FAMILY 2, SUBFAMILY
A, POLYPEPTIDE 6)
3lw2 PLASMINOGEN
ACTIVATOR INHIBITOR
1

(Mus
musculus)
5 / 10 PHE A 278
ILE A 326
ILE A 237
LEU A 275
PHE A 358
None
1.11A 1z11D-3lw2A:
undetectable
1z11D-3lw2A:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WEK_A_DIFA1376_1
(ZINC-BINDING ALCOHOL
DEHYDROGENASE
DOMAIN-CONTAINING
PROTEIN 2)
3lw2 PLASMINOGEN
ACTIVATOR INHIBITOR
1

(Mus
musculus)
4 / 8 LEU A 165
LEU A  46
ALA A  44
MET A 295
None
0.98A 2wekA-3lw2A:
undetectable
2wekA-3lw2A:
22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VQR_B_ACTB1002_0
(PUTATIVE
OXIDOREDUCTASE)
3lw2 PLASMINOGEN
ACTIVATOR INHIBITOR
1

(Mus
musculus)
4 / 5 ASP A 297
GLY A  52
ASP A 305
THR A  50
None
1.11A 3vqrB-3lw2A:
undetectable
3vqrB-3lw2A:
23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AC9_C_DXCC1479_0
(MJ0495-LIKE PROTEIN)
3lw2 PLASMINOGEN
ACTIVATOR INHIBITOR
1

(Mus
musculus)
4 / 5 THR A  93
ILE A  91
GLU A  90
PHE A 372
None
1.45A 4ac9C-3lw2A:
undetectable
4ac9C-3lw2A:
21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ACA_C_DXCC1479_0
(TRANSLATION
ELONGATION FACTOR
SELB)
3lw2 PLASMINOGEN
ACTIVATOR INHIBITOR
1

(Mus
musculus)
4 / 5 THR A  93
ILE A  91
GLU A  90
PHE A 372
None
1.43A 4acaC-3lw2A:
undetectable
4acaC-3lw2A:
21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C49_A_HCYA1384_1
(CORTICOSTEROID-BINDI
NG GLOBULIN)
3lw2 PLASMINOGEN
ACTIVATOR INHIBITOR
1

(Mus
musculus)
5 / 12 ALA A 335
SER A 336
VAL A 324
ASN A 167
SER A  40
None
1.07A 4c49A-3lw2A:
43.0
4c49A-3lw2A:
28.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4M11_B_MXMB606_1
(PROSTAGLANDIN G/H
SYNTHASE 2)
3lw2 PLASMINOGEN
ACTIVATOR INHIBITOR
1

(Mus
musculus)
6 / 12 MET A 298
VAL A 317
VAL A  42
LEU A  46
ALA A 340
LEU A 286
None
1.40A 4m11B-3lw2A:
undetectable
4m11B-3lw2A:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MBS_B_MRVB1101_2
(CHIMERA PROTEIN OF
C-C CHEMOKINE
RECEPTOR TYPE 5 AND
RUBREDOXIN)
3lw2 PLASMINOGEN
ACTIVATOR INHIBITOR
1

(Mus
musculus)
4 / 5 TYR A 228
THR A 251
LEU A 254
THR A 369
None
1.49A 4mbsB-3lw2A:
undetectable
4mbsB-3lw2A:
22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKV_A_AERA601_2
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)
3lw2 PLASMINOGEN
ACTIVATOR INHIBITOR
1

(Mus
musculus)
4 / 5 LEU A 273
ASP A 222
GLU A 225
VAL A 361
None
1.25A 4nkvA-3lw2A:
undetectable
4nkvA-3lw2A:
21.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKV_B_AERB601_2
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)
3lw2 PLASMINOGEN
ACTIVATOR INHIBITOR
1

(Mus
musculus)
4 / 5 ARG A 271
ASP A 222
GLU A 225
VAL A 361
None
1.05A 4nkvB-3lw2A:
undetectable
4nkvB-3lw2A:
21.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4W5O_A_IPHA906_0
(PROTEIN ARGONAUTE-2)
3lw2 PLASMINOGEN
ACTIVATOR INHIBITOR
1

(Mus
musculus)
4 / 5 PHE A  15
PRO A  36
VAL A  39
ALA A  12
None
1.33A 4w5oA-3lw2A:
undetectable
4w5oA-3lw2A:
18.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Z4D_A_IPHA904_0
(PROTEIN ARGONAUTE-2)
3lw2 PLASMINOGEN
ACTIVATOR INHIBITOR
1

(Mus
musculus)
4 / 5 PHE A  15
PRO A  36
VAL A  39
ALA A  12
None
1.34A 4z4dA-3lw2A:
undetectable
4z4dA-3lw2A:
18.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Z4E_A_IPHA906_0
(PROTEIN ARGONAUTE-2)
3lw2 PLASMINOGEN
ACTIVATOR INHIBITOR
1

(Mus
musculus)
4 / 5 PHE A  15
PRO A  36
VAL A  39
ALA A  12
None
1.31A 4z4eA-3lw2A:
undetectable
4z4eA-3lw2A:
18.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EWJ_D_QELD503_1
(NMDA GLUTAMATE
RECEPTOR SUBUNIT
GLUTAMATE RECEPTOR
IONOTROPIC, NMDA 2B)
3lw2 PLASMINOGEN
ACTIVATOR INHIBITOR
1

(Mus
musculus)
5 / 12 THR A  13
LEU A 258
PRO A  36
GLN A  21
THR A 215
None
1.39A 5ewjC-3lw2A:
undetectable
5ewjD-3lw2A:
undetectable
5ewjC-3lw2A:
22.42
5ewjD-3lw2A:
22.70